InMed Pharmaceuticals Inc. products
Other Products
InMed Prodiol - Bioidentical Cannabinoids for your Health and Wellness Products
Our subsidiary, BayMedica, is a B2B supplier of highly pure, premium bioidentical rare cannabinoids as raw ingredients for health and wellness products. BayMedica has been able to reliably manufacture rare, minor cannabinoids that are bioidentical to those found in the plant. This means that our cannabinoids have an identical molecular structure to the cannabinoids found in the Cannabis plant. BayMedica has manufactured these rare cannabinoids at commercial scale as core ingredients in your health and wellness products. For health and wellness product manufacturers, our rare cannabinoid ingredients for B2B sale include tetrahydrocannabivarin (d9-THCV), cannabidivarin (CBDV), cannabichromene (CBC) and ultra-rare cannabinoid cannabicitran (CBT) available in any quantity needed.
IntegraSyn - Integrated Cannabinoid Synthesis System
IntegraSyn is InMed’s integrated cannabinoid synthesis system to manufacture pharmaceutical-grade cannabinoids. Our goal has always been to achieve an efficient, scalable, flexible and economical solution to produce cannabinoids with bio-identical structures to those found in nature. IntegraSyn™ is designed to produce rare cannabinoids for pharmaceutical use. In addition to IntegraSyn™, InMed’s subsidiary, BayMedica, utilizes biosynthesis and chemical synthesis to manufacture rare cannabinoids for the health and wellness industry
Pharmaceutical
InMed - Topical Eye Drop for the Treatment of Glaucoma
INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential to provide neuroprotection and to reduce intraocular pressure of the eye.
InMed - Cannabinol Topical Cream for the Treatment of Epidermolysis Bullosa
INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755 cream for EB is the first, and currently the only, cannabinol formulation being tested in clinical trials as a therapeutic product.